In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024

Abstract
Apex Market Research has published a new report titled ”Global In-Vitro Toxicology/Toxicity Testing Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global in vitro toxicology testing market is projected to reach USD 12.7 billion by 2024 from USD 8.1 billion in 2019, at a CAGR of 9.3%. The report offers in-depth insights, revenue details, and other vital information regarding the global In-Vitro Toxicology/Toxicity Testing market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the In-Vitro Toxicology/Toxicity Testing market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global In-Vitro Toxicology/Toxicity Testing market report offers in-depth insights, revenue details, and other vital information regarding the global In-Vitro Toxicology/Toxicity Testing market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of In-Vitro Toxicology/Toxicity Testing market. The major players operating into In-Vitro Toxicology/Toxicity Testing Market include: Thermo Fisher Scientific Inc. (US)
Covance (US)
Bio-Rad Laboratories
Inc. (US)
GE Healthcare (US)
Eurofins Scientific SE (Luxembourg)
Merck KGaA (Germany)
Charles River Laboratories International
Inc. (US)
Catalent
Inc. (US)
Cyprotex (UK)
SGS S.A. (Switzerland)
QIAGEN N.V. (Germany)
Promega Corporation (US)
Gentronix Limited (UK)
BioIVT (US)
and MB Research Laboratories (US) Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD)
Covered Segments Product & Service, Technology, Toxicity Endpoint & Test, Industry, Method, and Region
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the In-Vitro Toxicology/Toxicity Testing market to forecast revenues and analyze trends in each of the following submarkets:

By Product & Service

  • Consumables
  • Assays
    • Bacterial Toxicity Assays
    • Enzyme Toxicity Assays
    • Cell-based Elisa & Western Blots
    • Receptor-binding Assays
    • Tissue Culture Assays
    • Other Assays
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays 
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

By Technology

  • Cell Culture Technologies 
  • High-throughput Technologies 
  • Toxicogenomics

By Industry

  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals
By geography, this market has been segregated into five regions with revenue and growth rate of In-Vitro Toxicology/Toxicity Testing from 2020 to 2027,
There are 13 chapters to put on view for In-Vitro Toxicology/Toxicity Testing Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: In-Vitro Toxicology/Toxicity Testing Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 In-Vitro Toxicology/Toxicity Testing Market Overview 1.1.1 In-Vitro Toxicology/Toxicity Testing Product Scope 1.1.2 Market Status and Outlook 1.2 Global In-Vitro Toxicology/Toxicity Testing Market Size and Analysis by Regions (2015-2019) 1.2.1 North America In-Vitro Toxicology/Toxicity Testing Market Status and Outlook 1.2.2 EU In-Vitro Toxicology/Toxicity Testing Market Status and Outlook 1.2.3 Japan In-Vitro Toxicology/Toxicity Testing Market Status and Outlook 1.2.4 China In-Vitro Toxicology/Toxicity Testing Market Status and Outlook 1.2.5 India In-Vitro Toxicology/Toxicity Testing Market Status and Outlook 1.2.6 Southeast Asia In-Vitro Toxicology/Toxicity Testing Market Status and Outlook 1.3 Global In-Vitro Toxicology/Toxicity Testing Market Segment By Product & Service
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.1 Consumables
1.3.1.1 Market Estimates And Forecast By Country, 2015-2027
1.3.2 Assays
1.3.2.1 Bacterial Toxicity Assays
1.3.2.2 Enzyme Toxicity Assays
1.3.2.3 Cell-based Elisa & Western Blots
1.3.2.4 Receptor-binding Assays
1.3.2.5 Tissue Culture Assays
1.3.2.6 Other Assays
1.3.2.7 Market Estimates And Forecast By Country, 2015-2027
1.3.2.6 Equipment
1.3.2.7 Market Estimates And Forecast By Country, 2015-2027
1.3.2.6 Software
1.3.2.7 Market Estimates And Forecast By Country, 2015-2027
1.3.2.6 Services
1.3.2.7 Market Estimates And Forecast By Country, 2015-2027
1.4 Global In-Vitro Toxicology/Toxicity Testing Market Segment By Method
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.1 Cellular Assays 
1.4.1.1 Market Estimates And Forecast By Country, 2015-2027
1.4.2 Biochemical Assays
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 In Silico Models
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Ex Vivo Models
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.5 Global In-Vitro Toxicology/Toxicity Testing Market Segment By Toxicity Endpoint
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.1 ADME
1.5.1.1 Market Estimates And Forecast By Country, 2015-2027
1.5.2 Skin Irritation, Corrosion, & Sensitization
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.3 Genotoxicity Testing
1.5.3.1 Market Estimates And Forecast By Country, 2015-2027
1.5.4 Cytotoxicity Testing
1.5.4.1 Market Estimates And Forecast By Country, 2015-2027
1.5.5 Ocular Toxicity
1.5.5.1 Market Estimates And Forecast By Country, 2015-2027
1.5.6 Organ Toxicity
1.5.6.1 Market Estimates And Forecast By Country, 2015-2027
1.5.7 Phototoxicity Testing
1.5.7.1 Market Estimates And Forecast By Country, 2015-2027
1.5.8 Dermal Toxicity
1.5.8.1 Market Estimates And Forecast By Country, 2015-2027
1.5.9 Other Toxicity Endpoints & Tests
1.5.9.1 Market Estimates And Forecast By Country, 2015-2027
1.6 Global In-Vitro Toxicology/Toxicity Testing Market Segment By Technology
1.6.1 Introduction
1.6.1.1 Market Estimates And Forecast 2015-2027
1.6.1 Cell Culture Technologies 
1.6.1.1 Market Estimates And Forecast By Country, 2015-2027
1.6.2 High-throughput Technologies 
1.6.2.1 Market Estimates And Forecast By Country, 2015-2027
1.6.3 Toxicogenomics
1.6.3.1 Market Estimates And Forecast By Country, 2015-2027
1.7 Global In-Vitro Toxicology/Toxicity Testing Market Segment By Industry
1.7.1 Introduction
1.7.1.1 Market Estimates And Forecast 2015-2027
1.7.1 Pharmaceuticals & Biopharmaceuticals
1.7.1.1 Market Estimates And Forecast By Country, 2015-2027
1.7.2 Cosmetic & Household Products
1.7.2.1 Market Estimates And Forecast By Country, 2015-2027
1.7.3 Food
1.7.3.1 Market Estimates And Forecast By Country, 2015-2027
1.7.4 Chemicals
1.7.4.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global In-Vitro Toxicology/Toxicity Testing Competition Analysis by Players 2.1 Global In-Vitro Toxicology/Toxicity Testing Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Thermo Fisher Scientific Inc. (US) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Thermo Fisher Scientific Inc. (US), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Covance (US) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Covance (US), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Bio-Rad Laboratories 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Bio-Rad Laboratories, In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Inc. (US) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Inc. (US), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 GE Healthcare (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 GE Healthcare (US), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Eurofins Scientific SE (Luxembourg) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Eurofins Scientific SE (Luxembourg), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Merck KGaA (Germany) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Merck KGaA (Germany), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Charles River Laboratories International 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Charles River Laboratories International, In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Inc. (US) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Inc. (US), In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Catalent 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Catalent, In-Vitro Toxicology/Toxicity Testing Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global In-Vitro Toxicology/Toxicity Testing Market Size Type (2015-2019) 4.1 Global In-Vitro Toxicology/Toxicity Testing Market Size by Type (2015-2019) Chapter 5 Global In-Vitro Toxicology/Toxicity Testing Market Size Application (2015-2019) 5.1 Global In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) 5.2 Potential Application of In-Vitro Toxicology/Toxicity Testing in Future 5.3 Top Consumer / End Users of In-Vitro Toxicology/Toxicity Testing Chapter 6 North America In-Vitro Toxicology/Toxicity Testing Development Status and Outlook 6.1 North America In-Vitro Toxicology/Toxicity Testing Market Size (2015-2019) 6.2 North America In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) Chapter 7 EU In-Vitro Toxicology/Toxicity Testing Development Status and Outlook 7.1 EU In-Vitro Toxicology/Toxicity Testing Market Size (2015-2019) 7.2 EU In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) Chapter 8 Japan In-Vitro Toxicology/Toxicity Testing Development Status and Outlook 8.1 Japan In-Vitro Toxicology/Toxicity Testing Market Size (2015-2019) 8.2 Japan In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) Chapter 9 China In-Vitro Toxicology/Toxicity Testing Development Status and Outlook 9.1 China In-Vitro Toxicology/Toxicity Testing Market Size and Forecast (2015-2019) 9.2 China In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) Chapter 10 India In-Vitro Toxicology/Toxicity Testing Development Status and Outlook 10.1 India In-Vitro Toxicology/Toxicity Testing Market Size and Forecast (2015-2019) 10.2 India In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) Chapter 11 Southeast Asia In-Vitro Toxicology/Toxicity Testing Development Status and Outlook 11.1 Southeast Asia In-Vitro Toxicology/Toxicity Testing Market Size and Forecast (2015-2019) 11.2 Southeast Asia In-Vitro Toxicology/Toxicity Testing Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global In-Vitro Toxicology/Toxicity Testing Market Size (Million USD) by Regions (2020-2027) 12.1. North America In-Vitro Toxicology/Toxicity Testing Revenue and Growth Rate (2020-2027) 12.1.2 EU In-Vitro Toxicology/Toxicity Testing Revenue and Growth Rate (2020-2027) 12.1.3 China In-Vitro Toxicology/Toxicity Testing Revenue and Growth Rate (2020-2027) 12.1.4 Japan In-Vitro Toxicology/Toxicity Testing Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia In-Vitro Toxicology/Toxicity Testing Revenue and Growth Rate (2020-2027) 12.1.6 India In-Vitro Toxicology/Toxicity Testing Revenue and Growth Rate (2020-2027) 12.2 Global In-Vitro Toxicology/Toxicity Testing Market Size by Application (2020-2027) Chapter 13 In-Vitro Toxicology/Toxicity Testing Market Dynamics 13.1 In-Vitro Toxicology/Toxicity Testing Market Opportunities 13.2 In-Vitro Toxicology/Toxicity Testing Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 In-Vitro Toxicology/Toxicity Testing Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 In-Vitro Toxicology/Toxicity Testing Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
2121

1545

OUR CLIENT